| Name | 5-Fluoro-2-[2-(4-morpholinyl)-5-(4-morpholinylsulfonyl)phenyl]-1,2-benzothiazol-3(2H)-one |
|---|---|
| Synonyms |
1,2-Benzisothiazol-3(2H)-one, 5-fluoro-2-[2-(4-morpholinyl)-5-(4-morpholinylsulfonyl)phenyl]-
5-Fluoro-2-[2-(4-morpholinyl)-5-(4-morpholinylsulfonyl)phenyl]-1,2-benzothiazol-3(2H)-one |
| Description | ML345 is a potent and selective insulin-degrading enzyme (IDE) small-molecule inhibitor, with an IC50 value of 188 nM. ML345 can be for use as a pharmacophore for drug development in diabetes research[1]. |
|---|---|
| Related Catalog | |
| Target |
IC50: 188 nM (IDE)[1] |
| References |
| Density | 1.5±0.1 g/cm3 |
|---|---|
| Boiling Point | 711.7±70.0 °C at 760 mmHg |
| Molecular Formula | C21H22FN3O5S2 |
| Molecular Weight | 479.54 |
| Flash Point | 384.2±35.7 °C |
| Exact Mass | 479.098480 |
| LogP | 1.32 |
| Vapour Pressure | 0.0±2.3 mmHg at 25°C |
| Index of Refraction | 1.658 |